Alpha-fetoprotein ELISA Kit Market Report – Research, Industry Analysis Reports and Market Demands

Global Alpha-fetoprotein ELISA Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Alpha-fetoprotein ELISA Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Sandwich ELISA
- 1.3.3 Competitive ELISA
- 1.3.4 Other
1.4 Market Analysis by Sample Type
- 1.4.1 Overview: Global Alpha-fetoprotein ELISA Kit Consumption Value by Sample Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Serum and Plasma
- 1.4.3 Cell Culture Supernatant
- 1.4.4 Other
1.5 Market Analysis by Kit Format
- 1.5.1 Overview: Global Alpha-fetoprotein ELISA Kit Consumption Value by Kit Format: 2021 Versus 2025 Versus 2032
- 1.5.2 48-Well Kit
- 1.5.3 96-Well Kit
- 1.5.4 Other
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Alpha-fetoprotein ELISA Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospitals
- 1.6.3 Independent Clinical Laboratories
- 1.6.4 Other
1.7 Global Alpha-fetoprotein ELISA Kit Market Size & Forecast
- 1.7.1 Global Alpha-fetoprotein ELISA Kit Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Alpha-fetoprotein ELISA Kit Sales Quantity (2021-2032)
- 1.7.3 Global Alpha-fetoprotein ELISA Kit Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Alpha-fetoprotein ELISA Kit by Manufacturer

3.1 Global Alpha-fetoprotein ELISA Kit Sales Quantity by Manufacturer (2021-2026)
3.2 Global Alpha-fetoprotein ELISA Kit Revenue by Manufacturer (2021-2026)
3.3 Global Alpha-fetoprotein ELISA Kit Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Alpha-fetoprotein ELISA Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Alpha-fetoprotein ELISA Kit Manufacturer Market Share in 2025
- 3.4.3 Top 6 Alpha-fetoprotein ELISA Kit Manufacturer Market Share in 2025
3.5 Alpha-fetoprotein ELISA Kit Market: Overall Company Footprint Analysis
- 3.5.1 Alpha-fetoprotein ELISA Kit Market: Region Footprint
- 3.5.2 Alpha-fetoprotein ELISA Kit Market: Company Product Type Footprint
- 3.5.3 Alpha-fetoprotein ELISA Kit Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Alpha-fetoprotein ELISA Kit Market Size by Region
- 4.1.1 Global Alpha-fetoprotein ELISA Kit Sales Quantity by Region (2021-2032)
- 4.1.2 Global Alpha-fetoprotein ELISA Kit Consumption Value by Region (2021-2032)
- 4.1.3 Global Alpha-fetoprotein ELISA Kit Average Price by Region (2021-2032)
4.2 North America Alpha-fetoprotein ELISA Kit Consumption Value (2021-2032)
4.3 Europe Alpha-fetoprotein ELISA Kit Consumption Value (2021-2032)
4.4 Asia-Pacific Alpha-fetoprotein ELISA Kit Consumption Value (2021-2032)
4.5 South America Alpha-fetoprotein ELISA Kit Consumption Value (2021-2032)
4.6 Middle East & Africa Alpha-fetoprotein ELISA Kit Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Alpha-fetoprotein ELISA Kit Sales Quantity by Type (2021-2032)
5.2 Global Alpha-fetoprotein ELISA Kit Consumption Value by Type (2021-2032)
5.3 Global Alpha-fetoprotein ELISA Kit Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Alpha-fetoprotein ELISA Kit Sales Quantity by Application (2021-2032)
6.2 Global Alpha-fetoprotein ELISA Kit Consumption Value by Application (2021-2032)
6.3 Global Alpha-fetoprotein ELISA Kit Average Price by Application (2021-2032)

7 North America

7.1 North America Alpha-fetoprotein ELISA Kit Sales Quantity by Type (2021-2032)
7.2 North America Alpha-fetoprotein ELISA Kit Sales Quantity by Application (2021-2032)
7.3 North America Alpha-fetoprotein ELISA Kit Market Size by Country
- 7.3.1 North America Alpha-fetoprotein ELISA Kit Sales Quantity by Country (2021-2032)
- 7.3.2 North America Alpha-fetoprotein ELISA Kit Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Alpha-fetoprotein ELISA Kit Sales Quantity by Type (2021-2032)
8.2 Europe Alpha-fetoprotein ELISA Kit Sales Quantity by Application (2021-2032)
8.3 Europe Alpha-fetoprotein ELISA Kit Market Size by Country
- 8.3.1 Europe Alpha-fetoprotein ELISA Kit Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Alpha-fetoprotein ELISA Kit Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Alpha-fetoprotein ELISA Kit Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Alpha-fetoprotein ELISA Kit Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Alpha-fetoprotein ELISA Kit Market Size by Region
- 9.3.1 Asia-Pacific Alpha-fetoprotein ELISA Kit Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Alpha-fetoprotein ELISA Kit Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Alpha-fetoprotein ELISA Kit Sales Quantity by Type (2021-2032)
10.2 South America Alpha-fetoprotein ELISA Kit Sales Quantity by Application (2021-2032)
10.3 South America Alpha-fetoprotein ELISA Kit Market Size by Country
- 10.3.1 South America Alpha-fetoprotein ELISA Kit Sales Quantity by Country (2021-2032)
- 10.3.2 South America Alpha-fetoprotein ELISA Kit Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Alpha-fetoprotein ELISA Kit Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Alpha-fetoprotein ELISA Kit Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Alpha-fetoprotein ELISA Kit Market Size by Country
- 11.3.1 Middle East & Africa Alpha-fetoprotein ELISA Kit Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Alpha-fetoprotein ELISA Kit Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Alpha-fetoprotein ELISA Kit Market Drivers
12.2 Alpha-fetoprotein ELISA Kit Market Restraints
12.3 Alpha-fetoprotein ELISA Kit Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Alpha-fetoprotein ELISA Kit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Alpha-fetoprotein ELISA Kit
13.3 Alpha-fetoprotein ELISA Kit Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Alpha-fetoprotein ELISA Kit Typical Distributors
14.3 Alpha-fetoprotein ELISA Kit Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Alpha-fetoprotein ELISA Kit market size was valued at US$ 64.32 million in 2025 and is forecast to a readjusted size of US$ 85.93 million by 2032 with a CAGR of 4.1% during review period.
Alpha-fetoprotein ELISA Kit is an enzyme-linked immunosorbent assay product used for quantitative or semi-quantitative measurement of alpha-fetoprotein in serum, plasma, cell culture supernatants, urine, tissue homogenates, or animal research samples. The most common assay format is a sandwich ELISA, typically consisting of pre-coated microplates, enzyme-conjugated antibodies, standards, calibrators, controls, sample diluent, wash buffer, chromogenic substrate, stop solution, and instructions for use. The test is used for AFP level assessment in hepatocellular carcinoma, germ cell tumors, pregnancy-related screening, liver disease research, tumor marker studies, and drug development. Key upstream materials include AFP capture antibodies, detection antibodies, recombinant AFP antigen, horseradish peroxidase or other enzyme labels, ELISA plates, TMB substrate, buffers, protein stabilizers, preservatives, plastic consumables, and packaging materials. Major downstream customers include hospital laboratories, oncology hospitals, maternal and child health institutions, independent clinical laboratories, universities, research institutes, pharmaceutical companies, CROs, and life science reagent distributors. On an ex-factory basis, global nominal production capacity in 2025 is estimated at about 34.20 million units, with actual sales volume of around 23.86 million units and an average ex-factory price of approximately USD 2.62 per unit. The industry's overall gross margin is estimated at about 45%-65%.
The current Alpha-fetoprotein ELISA Kit market has entered a mature stage, with clinical growth clearly lower than in the early period of tumor marker testing adoption. AFP remains a commonly used serum marker in hepatocellular carcinoma, germ cell tumors, and pregnancy-related screening, but large hospitals and high-throughput clinical laboratories have gradually shifted toward chemiluminescence, electrochemiluminescence, and fully automated immunoassay platforms. The advantages of ELISA kits lie mainly in low cost, low equipment requirements, broad laboratory compatibility, and suitability for low-throughput batch testing. As a result, AFP ELISA kits still maintain stable demand in research laboratories, primary medical institutions, selected export markets, and teaching laboratories.
Future market development is unlikely to be driven by rapid volume expansion. Instead, it will be shaped by product quality improvement, stable research demand, continued use in low-cost testing markets, and regional demand shifts. In clinical diagnostics, incremental demand will continue to be partly absorbed by automated immunoassay platforms, and the share of AFP ELISA in core testing menus of tertiary hospitals may decline further. In research settings, however, long-term demand will remain supported by liver cancer models, hepatocyte differentiation studies, drug toxicology, reproductive medicine, and tumor marker mechanism research. For manufacturers, competition will shift from simple price competition toward antibody-pair quality, lot-to-lot consistency, sensitivity, linear range, sample compatibility, documentation quality, and channel responsiveness.
Market growth is mainly supported by the continued global disease burden of liver cancer, sustained demand for AFP quantification in basic and translational research, preference for economical immunoassay solutions in low-throughput laboratories, and procurement demand for cost-effective reagents in developing markets. Research-use AFP ELISA products also benefit from long-term applications in universities, research institutes, pharmaceutical companies, and CROs for cell culture studies, animal models, liver disease mechanisms, and tumor marker research. China, India, Southeast Asia, Latin America, and parts of the Middle East are expected to provide incremental demand through low-cost reagent distribution channels.
Key barriers include replacement by automated clinical platforms, product homogenization, fragmentation of research reagent brands, greater price transparency, and uneven product quality among suppliers. Some low-priced ELISA products may suffer from lot-to-lot variation, unstable standard curves, unclear antibody specificity, or incomplete documentation, which can affect repeat purchases and brand trust. For clinical diagnostic use, regulatory registration, quality management systems, external quality assessment participation, and stable batch supply remain important entry barriers for hospital channels. Going forward, the industry is likely to become more segmented: international life science reagent brands will continue to hold stronger positions in high-end research markets, while regional and Chinese suppliers will mainly compete through cost efficiency, fast delivery, and localized channels.
This report is a detailed and comprehensive analysis for global Alpha-fetoprotein ELISA Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Alpha-fetoprotein ELISA Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Alpha-fetoprotein ELISA Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Alpha-fetoprotein ELISA Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Alpha-fetoprotein ELISA Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alpha-fetoprotein ELISA Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alpha-fetoprotein ELISA Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, Abcam, Bio-Techne, Fujirebio, DRG International, BioVendor Group, RayBiotech, MyBioSource, Novus Biologicals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Alpha-fetoprotein ELISA Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sandwich ELISA
Competitive ELISA
Other
Market segment by Sample Type
Serum and Plasma
Cell Culture Supernatant
Other
Market segment by Kit Format
48-Well Kit
96-Well Kit
Other
Market segment by Application
Hospitals
Independent Clinical Laboratories
Other
Major players covered
Thermo Fisher Scientific
Merck
Abcam
Bio-Techne
Fujirebio
DRG International
BioVendor Group
RayBiotech
MyBioSource
Novus Biologicals
CUSABIO
Elabscience
NeoBioscience
Jianglai Biotechnology
COIBO Bio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alpha-fetoprotein ELISA Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alpha-fetoprotein ELISA Kit, with price, sales quantity, revenue, and global market share of Alpha-fetoprotein ELISA Kit from 2021 to 2026.
Chapter 3, the Alpha-fetoprotein ELISA Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha-fetoprotein ELISA Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Alpha-fetoprotein ELISA Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alpha-fetoprotein ELISA Kit.
Chapter 14 and 15, to describe Alpha-fetoprotein ELISA Kit sales channel, distributors, customers, research findings and conclusion.

Buy now